A
Ajanta Pharma
Sustainability Report and Carbon Intensity Rankings
Is Ajanta Pharma doing their part?
Their DitchCarbon score is 43
Ajanta Pharma has a DitchCarbon Score of 43 out of 100, indicating moderate performance in sustainability practices. This score reflects the company’s current carbon intensity level, suggesting there is significant room for improvement in reducing emissions. A higher score would denote stronger efforts in minimizing carbon intensity and advancing their sustainability agenda.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Ajanta Pharma is part of the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Ajanta Pharma is located in India, a region with a very high carbon intensity rating. This suggests that the company’s operations may be associated with higher greenhouse gas emissions, potentially impacting its sustainability efforts negatively.
Unlock 30+ emissions data points on Ajanta Pharma
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Ajanta Pharma
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
1.71%
...this company is doing 1.71% better in emissions than the industry average.
Ajanta Pharma Limited, founded in 1973 and based in Mumbai, India, operates within the pharmaceutical industry. The company specializes in Branded Generic business across India and emerging markets, as well as Generic business in the USA, with a focus on therapeutic areas such as Cardiology, Dermatology, Ophthalmology, and Pain Management. Ajanta Pharma boasts state-of-the-art research and manufacturing facilities, with a strong commitment to R&D and a growing portfolio of products, including several market-first launches.
emission intelligence's platform recommendations for Ajanta Pharma
Ajanta Pharma should consider implementing green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 0.3%.
Bad news, Ajanta Pharma hasn't committed to SBTi goals yet
Ajanta Pharma has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not publicly defined or committed to concrete targets to reduce greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.